The discovery, complex crystal structure, and recognition mechanism of a novel natural PDE4 inhibitor from Selaginella pulvinata

被引:38
作者
Huang, Yiyou [1 ]
Liu, Xin [1 ]
Wu, Deyan [1 ]
Tang, Guihua [1 ]
Lai, Zengwei [1 ]
Zheng, Xuehua [2 ]
Yin, Sheng [1 ]
Luo, Hai-Bin [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Sch Pharmaceut Sci, Guangzhou 511436, Guangdong, Peoples R China
[3] Natl Univ Def Technol, Collaborat Innovat Ctr High Performance Comp, Changsha 410073, Hunan, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Phosphodiesterase-4; Natural inhibitor; Selaginpulvilins K; Crystal structure; Recognition mechanism; OBSTRUCTIVE PULMONARY-DISEASE; PHOSPHODIESTERASE-4; INHIBITORS; MOLECULAR-BASIS; SELECTIVITY; DERIVATIVES; DESIGN;
D O I
10.1016/j.bcp.2017.01.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Phosphodiesterase-4 (PDE4) is an important drug target for treatment of inflammation-related diseases. Till now, natural PDE4 inhibitors are rare and their co-crystal structures with PDE4 are hardly available. In the present study, selaginpulvilins K and L (1 and 2), two novel fluorene derivatives, were isolated from a traditional Chinese medicine Selaginella pulvinata and exhibited remarkable inhibition against phosphodiesterase-4D (PDE4D) at IC50 11 nM and 90 nM, respectively. Compound 1 also showed a good selectivity across PDE families with the selective fold ranging from 30 to 909. To understand the recognition mechanism of selaginpulvilins towards PDE4, the crystal structure of PDE4D bound with 1 was successfully determined by the X-ray diffraction method and presented an unusual binding mode in which the stretched skeleton of the inhibitor bound shallowly to the active site but had interactions with multi sub-pockets, such as Q, HC, M, and S, especially strong interaction with the metal region. Assisted with molecular modeling, the structure-activity relationship and the selectivity of selaginpulvilins were also well explored, which would facilitate the future rational inhibitor design or structural optimizations. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 42 条
[1]  
Adams P. D., ACTA CRYSTALLOGR D, V66
[2]  
[Anonymous], 2010, VERS 2010 10
[3]  
[Anonymous], 2010, ACC DISC STUD VERS 2
[4]   Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use [J].
Bender, Andrew T. ;
Beavo, Joseph A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :488-520
[5]   PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL [J].
Bramucci, Emanuele ;
Paiardini, Alessandro ;
Bossa, Francesco ;
Pascarella, Stefano .
BMC BIOINFORMATICS, 2012, 13
[6]   Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety [J].
Burgin, Alex B. ;
Magnusson, Olafur T. ;
Singh, Jasbir ;
Witte, Pam ;
Staker, Bart L. ;
Bjornsson, Jon M. ;
Thorsteinsdottir, Margret ;
Hrafnsdottir, Sigrun ;
Hagen, Timothy ;
Kiselyov, Alex S. ;
Stewart, Lance J. ;
Gurney, Mark E. .
NATURE BIOTECHNOLOGY, 2010, 28 (01) :63-U93
[7]   Four new selaginellin derivatives from Selaginella pulvinata: mechanism of racemization process in selaginellins with quinone methide [J].
Cao, Yuan ;
Yao, Yi ;
Huang, Xiao-Jun ;
Oberer, Lukas ;
Wagner, Trixie ;
Guo, Jian-Ming ;
Gu, Wei ;
Liu, Wei-Da ;
Lv, Gui-Xia ;
Shen, Yong-Nian ;
Duan, Jin-Ao .
TETRAHEDRON, 2015, 71 (10) :1581-1587
[8]   Structural basis for the activity of drugs that inhibit phosphodiesterases [J].
Card, GL ;
England, BP ;
Suzuki, Y ;
Fong, D ;
Powell, B ;
Lee, B ;
Luu, C ;
Tabrizizad, M ;
Gillette, S ;
Ibrahim, PN ;
Artis, DR ;
Bollag, G ;
Milburn, MV ;
Kim, SH ;
Schlessinger, J ;
Zhang, KYJ .
STRUCTURE, 2004, 12 (12) :2233-2247
[9]  
Case D.A., 2014, Amber 14, V14
[10]   Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor [J].
Chen, Shang-Ke ;
Zhao, Peng ;
Shao, Yong-Xian ;
Li, Zhe ;
Zhang, Cuixian ;
Liu, Peiqing ;
He, Xixin ;
Luo, Hai-Bin ;
Hu, Xiaopeng .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) :3261-3264